TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced its joint partnership sales plans for the commercial launch of its newest software release designed to support an innovative and easy to use wireless, 12 lead ECG, vital signs, arrhythmia and ischemia monitoring wearable smart garment manufactured by Israel-based HealthWatch Technologies Ltd. (“HealthWatch”).
The two companies began co-development efforts last year to bring to market an FDA-cleared (USA sales) and CE-approved (European sales) easy to use remote 12- lead monitoring, ECG wearable smart garment solution. In June 2017, the companies confirmed they were awarded a grant through the Canadian-Israeli Industrial R&D Foundation (“CIIRDF”) to fast-track their development efforts. In September of 2018, the companies executed a co-marketing agreement that would expand their sales and marketing scope for this unique wearable ECG monitoring solution to include sales into Europe.
With CardioComm’s completion of software and hardware quality system documentation, the companies have a green light for the sales launch of the wearable, remote ECG monitoring technology. HealthWatch will leverage a large number of pre-scheduled sales and marketing meetings during Medica, Europe’s largest medical exposition, to deliver a very strong marketing message. Following Medica, both companies will collaborate to launch the solution to CardioComm’s current USA based GEMS™ WIN accounts who will be able to include use of the Master Caution® garment to their current GEMS™ WIN license without the need to add new management software and/or learn new workflows.
The companies will focus marketing efforts on groups active in mobile cardiac telemetry services, arrhythmia and prolonged QT interval screening, ECG monitoring as an extension to in-hospital/clinic services, and to those involved in providing long-term managed care support for people living with chronic medical conditions. Both GEMS™ WIN and GEMS™ Flex applications are scalable and can support enterprise applications to concurrently monitor very high patient volumes. The new wearable/software ECG monitoring product is a superior solution over the ECG recording products typically used today with patches, straps, electrodes and/or cables. The new solution is also perfectly suited for athletes and sports enthusiasts who routinely monitor their ECGs thereby opening up new markets for CardioComm and HealthWatch.
To learn more about CardioComm’s products and for further updates regarding HeartCheck™ ECG device integrations please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.